Barclays analyst Jeffrey Bernstein maintains Wingstop (NASDAQ:WING) with a Overweight and raises the price target from $184 to $194.
Raymond James Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $85
Raymond James analyst Jayson Bedford maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $120 to $85.